Dr. Reddy’s releases generic version of Strattera

Print Friendly, PDF & Email
HYDERABAD, India and PRINCETON, N.J . — Dr. Reddy’s Laboratories announced the roll out of its atomoxetine capsules. The product is for the treatment of attention-deficit/hyperactivity disorder, is a generic version of Eli Lilly’s Strattera.

Dr. Reddy’s atomoxetine capsules are available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg with a 30-count bottle size.

Both the Strattera brand and generic had a market value of approximately $304 million for the most recent twelve months ending in August 2018, according to IQVIA data.




Comments are closed.